ZeptoMetrix
Biotechnology ResearchNew York, United States51-200 Employees
ZeptoMetrix is a biotechnology research company headquartered in Buffalo, New York, with a staff of between 51 and 200 employees. It focuses on infectious disease research and diagnostics, offering a range of research products and services and collaborating with scientists globally under a mission to be a partner to its customers. The company develops and provides molecular diagnostic controls and panels, including NATtrol and PROtrol products, and has expanded to cover respiratory and coronavirus controls. In 2025 ZeptoMetrix launched NATtrol Influenza A H5N1 Quantitative Stock and an H5N1 control using phage-like particle technology, and it partnered with LEX Diagnostics Limited to tailor products to the LEX system. The company obtained an IVDR Quality Management System certificate from the British Standards Institution in 2023, reflecting its regulatory compliance in diagnostics.